Approach to Optimize Anti-TNF-α Therapy in Patients With IBD.
about
miRNA-133a-UCP2 pathway regulates inflammatory bowel disease progress by influencing inflammation, oxidative stress and energy metabolism.Biologics-induced interstitial lung diseases in rheumatic patients: facts and controversies.Hydrogen-rich water protects against inflammatory bowel disease in mice by inhibiting endoplasmic reticulum stress and promoting heme oxygenase-1 expression.Lactococcus lactis As a Versatile Vehicle for Tolerogenic Immunotherapy.β-Sitosterol and stigmasterol ameliorate dextran sulfate sodium-induced colitis in mice fed a high fat Western-style diet.
P2860
Approach to Optimize Anti-TNF-α Therapy in Patients With IBD.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Approach to Optimize Anti-TNF-α Therapy in Patients With IBD.
@en
Approach to Optimize Anti-TNF-α Therapy in Patients With IBD.
@nl
type
label
Approach to Optimize Anti-TNF-α Therapy in Patients With IBD.
@en
Approach to Optimize Anti-TNF-α Therapy in Patients With IBD.
@nl
prefLabel
Approach to Optimize Anti-TNF-α Therapy in Patients With IBD.
@en
Approach to Optimize Anti-TNF-α Therapy in Patients With IBD.
@nl
P2093
P2860
P1476
Approach to Optimize Anti-TNF-α Therapy in Patients With IBD.
@en
P2093
Fukiko Komaki
Russell Cohen
Yuga Komaki
P2860
P2888
P356
10.1007/S11938-016-0079-X
P577
2016-02-12T00:00:00Z